Business Wire

CA-DENODO

22.5.2024 13:01:32 CEST | Business Wire | Press release

Share
Denodo Redoubles Focus on Energy and Utilities

Denodo, a leader in data management, announced that the company is expanding its efforts to provide energy and utility companies with the necessary data management capabilities to gain advanced capabilities and meet new renewable energy requirements, all while remaining in compliance with increasingly stringent regulatory demands.

Facing numerous challenges, including generating, managing, and consuming new, decarbonized and increasingly digitized sources of energy; maintaining resilience and sustainability in a time of change; developing new technologies such as virtual power plants (VPPs) based on intelligent operations; all while managing a rising number of environmental, social, and governance (ESG) and sustainability initiatives; energy and utility companies need to be able to manage data so that it helps to overcome these challenges, rather than adding to them.

The Denodo Platform facilitates this by providing real-time access to data across myriad distributed energy resources, while enabling the establishment of a unified semantic layer over all data sources, to deliver data when it is needed, in the language required by each data consumer. This provides energy and utility companies with the foundation to overcome myriad known and unknown challenges. The Denodo Platform enables such capabilities as continuous monitoring and control, and makes it possible for VPP operators to make fast, informed decisions in response to changes in energy demand, pricing, and environmental conditions. By enabling such capabilities, the Denodo Platform provides energy and utility companies with a reliable foundation for innovation.

Denodo has a strong heritage in providing impactful data management solutions to energy and utility companies, such as VTTI, a Netherlands-based energy storage and developer of critical energy infrastructure; BHP, a global resources company headquartered in Melbourne, Australia; Engie Mexico, an energy company that is committed to bringing energy to the people of Mexico; and Suez, a French multinational corporation with operations in water, electricity, natural gas supply, and waste management.

Hans Geurts, chief information officer for VTTI, says, “As a rapidly growing organization in an uncertain geopolitical environment, laying a strong data foundation was critical for us to become data-driven. The Denodo Platform has helped us in simplifying and standardizing our data infrastructure, while boosting our business resilience.” The Denodo Platform acts as VTTI’s single source of truth for enterprise resource planning (ERP) data. The company leverages it to synthesize, combine, and analyze operational insights to improve ways of working and address inefficiencies in the operational micro-steps at the company’s terminals. It also helps VTTI to visualize and understand product trade flows through the terminals and various modes of transport, helping VTTI’s commercial teams to better serve customers.

Joshua Fletcher, superintendent HSE, Reporting at BHP, made similar statements about the effect that the Denodo Platform had on the company’s business. “The Denodo Platform helps us to reduce the overall size of the data sets that need to be moved over the network. It helped us to create a logical data fabric that makes our data assets reusable and can be consumed by users spread across the globe.”

Luis Guadarrama, senior manager, Data Analytics and Innovation at Engie Mexico, says, “The Denodo Platform delivers data quickly and easily, which helps us to deliver value to the business and democratize data access. Our business users might not understand the technical part, but they do understand that there’s something called ‘the Denodo Platform’ that helps them to connect to data in an easier way, to make better decisions.” Engie Mexico leveraged the Denodo Platform to enable a variety of strategic initiatives, including web services that help hundreds of thousands of customers to balance their use of natural gas, chatbots that assist in problem resolution, and machine learning (ML) algorithms that analyze the behavior patterns of business-to-consumer gas customers.

Denodo believes that VPPs are the power plants of the future. VPPs can run energy in the cloud, and they can supply renewable energy on-demand, through innovative web-based interfaces that can remotely link and manage homes with solar and battery storage. Additionally, VPPs can feed power back to the grid during peak times, to relieve the load and keep the network stable.

Denodo also believes that data-driven, intelligent operations is a critical capability that can greatly assist utility CIOs in designing fit-for-the-future assets that bridge physical and digital phenomena. The Denodo Platform facilitates the development of intelligent operations and VPPs through diverse capabilities, including distributed energy resource management, predictive analytics for maintenance, and optimization of energy assets.

“Advanced data management technology will be essential in enabling new capabilities that oil and gas companies need to thrive, both now and beyond the energy transition,” said Paul Moxon, SVP Data Architecture and Chief Evangelist at Denodo. “Power plants of the future will operate in an eco-centric, distributed manner, enabling the data-driven, intelligent VPPs of the future. The Denodo Platform, with its ability to provide real-time data access to increasingly diverse data sources, will underpin success by providing energy and utility business users with access to data at the speed of business.”

For more information:

About Denodo

Denodo is a leader in data management. The award-winning Denodo Platform is the leading logical data management platform for delivering data in the language of business, at the speed of business, for all data-related initiatives across the organization. Realizing more than 400% ROI and millions of dollars in benefits, Denodo’s customers across enterprises in 30+ industries all over the world have received payback in less than six months. For more information, visit denodo.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522149387/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release

Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release

MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye